Correlation Between JPMorgan Chase and Adamis Pharma

Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Adamis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Adamis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between JPMorgan Chase Co and Adamis Pharma, you can compare the effects of market volatilities on JPMorgan Chase and Adamis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Adamis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Adamis Pharma.

Diversification Opportunities for JPMorgan Chase and Adamis Pharma

0.0

Correlation Coefficient

JPMorgan Chase  Adamis Pharma

Pay attention - limited upside

The 3 months correlation between JPMorgan and Adamis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Adamis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adamis Pharma and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Adamis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adamis Pharma has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Adamis Pharma go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Adamis Pharma

Considering the 90-day investment horizon JPMorgan Chase Co is expected to generate 0.2 times more return on investment than Adamis Pharma. However, JPMorgan Chase Co is 4.89 times less risky than Adamis Pharma. It trades about 0.1 of its potential returns per unit of risk. Adamis Pharma is currently generating about -0.23 per unit of risk. If you would invest  13,490  in JPMorgan Chase Co on October 27, 2024 and sell it today you would earn a total of  12,994  from holding JPMorgan Chase Co or generate 96.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	23.68%
Values	Daily Returns

JPMorgan Chase Co  vs.  Adamis Pharma

JPMorgan Chase

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.

Adamis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with JPMorgan Chase and Adamis Pharma

The main advantage of trading using opposite JPMorgan Chase and Adamis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Adamis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adamis Pharma will offset losses from the drop in Adamis Pharma's long position.

The idea behind JPMorgan Chase Co and Adamis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.